These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519 [TBL] [Abstract][Full Text] [Related]
4. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. Li L; Miano JM; Mercer B; Olson EN J Cell Biol; 1996 Mar; 132(5):849-59. PubMed ID: 8603917 [TBL] [Abstract][Full Text] [Related]
5. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Gan Q; Yoshida T; Li J; Owens GK Circ Res; 2007 Oct; 101(9):883-92. PubMed ID: 17823374 [TBL] [Abstract][Full Text] [Related]
6. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Kim S; Ip HS; Lu MM; Clendenin C; Parmacek MS Mol Cell Biol; 1997 Apr; 17(4):2266-78. PubMed ID: 9121477 [TBL] [Abstract][Full Text] [Related]
7. Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries. Siow RC; Mallawaarachchi CM; Weissberg PL Cardiovasc Res; 2003 Jul; 59(1):212-21. PubMed ID: 12829192 [TBL] [Abstract][Full Text] [Related]
8. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Guzman RJ; Lemarchand P; Crystal RG; Epstein SE; Finkel T Circulation; 1993 Dec; 88(6):2838-48. PubMed ID: 8252697 [TBL] [Abstract][Full Text] [Related]
9. Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation. Wills KN; Mano T; Avanzini JB; Nguyen T; Antelman D; Gregory RJ; Smith RC; Walsh K Gene Ther; 2001 Dec; 8(24):1847-54. PubMed ID: 11821938 [TBL] [Abstract][Full Text] [Related]
10. A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer. Appleby CE; Kingston PA; David A; Gerdes CA; Umaña P; Castro MG; Lowenstein PR; Heagerty AM Gene Ther; 2003 Sep; 10(18):1616-22. PubMed ID: 12907954 [TBL] [Abstract][Full Text] [Related]
11. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877 [TBL] [Abstract][Full Text] [Related]
12. SM22alpha promoter targets gene expression to vascular smooth muscle cells in vitro and in vivo. Akyürek LM; Yang ZY; Aoki K; San H; Nabel GJ; Parmacek MS; Nabel EG Mol Med; 2000 Nov; 6(11):983-91. PubMed ID: 11147575 [TBL] [Abstract][Full Text] [Related]
13. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Madsen CS; Regan CP; Hungerford JE; White SL; Manabe I; Owens GK Circ Res; 1998 May; 82(8):908-17. PubMed ID: 9576110 [TBL] [Abstract][Full Text] [Related]
14. Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta. Roks AJ; Henning RH; Buikema H; Pinto YM; Kraak MJ; Tio RA; de Zeeuw D; Haisma HJ; Wilschut J; van Gilst WH Gene Ther; 2002 Jan; 9(2):95-101. PubMed ID: 11857067 [TBL] [Abstract][Full Text] [Related]
15. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Zoldhelyi P; McNatt J; Xu XM; Loose-Mitchell D; Meidell RS; Clubb FJ; Buja LM; Willerson JT; Wu KK Circulation; 1996 Jan; 93(1):10-7. PubMed ID: 8616915 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
17. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Steg PG; Feldman LJ; Scoazec JY; Tahlil O; Barry JJ; Boulechfar S; Ragot T; Isner JM; Perricaudet M Circulation; 1994 Oct; 90(4):1648-56. PubMed ID: 7923648 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Arbuthnot PB; Bralet MP; Le Jossic C; Dedieu JF; Perricaudet M; Bréchot C; Ferry N Hum Gene Ther; 1996 Aug; 7(13):1503-14. PubMed ID: 8864751 [TBL] [Abstract][Full Text] [Related]
19. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo. Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840 [TBL] [Abstract][Full Text] [Related]
20. A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver. Tietge UJ; Kozarsky KF; Donahee MH; Rader DJ J Gene Med; 2003 Jul; 5(7):567-75. PubMed ID: 12825196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]